An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jun 13, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to support patients who have locally advanced rectal cancer, which means their cancer is at stage II or III and requires a combination of treatments. The study will test a brief program designed to help patients feel more confident and in control as they start their treatment. This is important because feeling empowered can lead to better health outcomes. The trial is currently recruiting participants who are 18 years or older, have recently decided to begin this type of therapy, and can communicate in English or with an interpreter.

If you or someone you know is interested in participating, it's essential to know that the trial is open to anyone who meets the age and treatment criteria, but individuals with other serious health issues or those who have had previous colorectal cancer treatments may not be eligible. Participants will engage in the psychoeducational program, which aims to provide helpful information and support during a challenging time. Overall, this study hopes to improve the experience of patients starting treatment for rectal cancer and help them feel more empowered throughout the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age≥18 years
• • 2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
• • 3. Able to complete study procedures English or with the assistance of an interpreter
• Exclusion Criteria:
• • 1. Comorbid health condition that would interfere with study participation, as identified by cancer care team
• • 2. Has undergone treatment for a prior colorectal cancer